Literature DB >> 27482114

CCN1/CYR61-mediated meticulous patrolling by Ly6Clow monocytes fuels vascular inflammation.

Beat A Imhof1, Stephane Jemelin1, Romain Ballet1, Christian Vesin2, Marc Schapira1, Melis Karaca2, Yalin Emre3.   

Abstract

Inflammation is characterized by the recruitment of leukocytes from the bloodstream. The rapid arrival of neutrophils is followed by a wave of inflammatory lymphocyte antigen 6 complex (Ly6C)-positive monocytes. In contrast Ly6C(low) monocytes survey the endothelium in the steady state, but their role in inflammation is still unclear. Here, using confocal intravital microscopy, we show that upon Toll-like receptor 7/8 (TLR7/8)-mediated inflammation of mesenteric veins, platelet activation drives the rapid mobilization of Ly6C(low) monocytes to the luminal side of the endothelium. After repeatedly interacting with platelets, Ly6C(low) monocytes commit to a meticulous patrolling of the endothelial wall and orchestrate the subsequent arrival and extravasation of neutrophils through the production of proinflammatory cytokines and chemokines. At a molecular level, we show that cysteine-rich protein 61 (CYR61)/CYR61 connective tissue growth factor nephroblastoma overexpressed 1 (CCN1) protein is released by activated platelets and enables the recruitment of Ly6C(low) monocytes upon vascular inflammation. In addition endothelium-bound CCN1 sustains the adequate patrolling of Ly6C(low) monocytes both in the steady state and under inflammatory conditions. Blocking CCN1 or platelets with specific antibodies impaired the early arrival of Ly6C(low) monocytes and abolished the recruitment of neutrophils. These results refine the leukocyte recruitment cascade model by introducing endothelium-bound CCN1 as an inflammation mediator and by demonstrating a role for platelets and patrolling Ly6C(low) monocytes in acute vascular inflammation.

Entities:  

Keywords:  CCN1; inflammation; monocyte; neutrophil; platelet

Mesh:

Substances:

Year:  2016        PMID: 27482114      PMCID: PMC4995973          DOI: 10.1073/pnas.1607710113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  67 in total

1.  Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.

Authors:  Frank Tacke; David Alvarez; Theodore J Kaplan; Claudia Jakubzick; Rainer Spanbroek; Jaime Llodra; Alexandre Garin; Jianhua Liu; Matthias Mack; Nico van Rooijen; Sergio A Lira; Andreas J Habenicht; Gwendalyn J Randolph
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

Authors:  Yuqing Huo; Andreas Schober; S Bradley Forlow; David F Smith; Matthew Craig Hyman; Steffen Jung; Dan R Littman; Christian Weber; Klaus Ley
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

3.  Protective roles of CX3CR1-mediated signals in toxin A-induced enteritis through the induction of heme oxygenase-1 expression.

Authors:  Masanori Inui; Yuko Ishida; Akihiko Kimura; Yumi Kuninaka; Naofumi Mukaida; Toshikazu Kondo
Journal:  J Immunol       Date:  2010-12-03       Impact factor: 5.422

Review 4.  Development of monocytes, macrophages, and dendritic cells.

Authors:  Frederic Geissmann; Markus G Manz; Steffen Jung; Michael H Sieweke; Miriam Merad; Klaus Ley
Journal:  Science       Date:  2010-02-05       Impact factor: 47.728

5.  Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients.

Authors:  Ryusuke Yano; Masahiro Yamamura; Katsue Sunahori; Kouji Takasugi; Jiro Yamana; Masanori Kawashima; Hirofumi Makino
Journal:  Acta Med Okayama       Date:  2007-04       Impact factor: 0.892

6.  Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8.

Authors:  Florian Heil; Hiroaki Hemmi; Hubertus Hochrein; Franziska Ampenberger; Carsten Kirschning; Shizuo Akira; Grayson Lipford; Hermann Wagner; Stefan Bauer
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

Review 7.  Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases.

Authors:  Janine M van Gils; Jaap Jan Zwaginga; Peter L Hordijk
Journal:  J Leukoc Biol       Date:  2008-10-23       Impact factor: 4.962

8.  Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior.

Authors:  Cedric Auffray; Darin Fogg; Meriem Garfa; Gaelle Elain; Olivier Join-Lambert; Samer Kayal; Sabine Sarnacki; Ana Cumano; Gregoire Lauvau; Frederic Geissmann
Journal:  Science       Date:  2007-08-03       Impact factor: 47.728

9.  Rapid immunomagnetic negative enrichment of neutrophil granulocytes from murine bone marrow for functional studies in vitro and in vivo.

Authors:  Mike Hasenberg; Anja Köhler; Susanne Bonifatius; Katrin Borucki; Monika Riek-Burchardt; Julia Achilles; Linda Männ; Kathleen Baumgart; Burkhart Schraven; Matthias Gunzer
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240

10.  Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.

Authors:  Jinpiao Lin; Ningli Li; Huijuan Chen; Can Liu; Bin Yang; Qishui Ou
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

View more
  22 in total

1.  Aortic aneurysm, CCN3 may solve the problem.

Authors:  Yalin Emre; Beat A Imhof
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration.

Authors:  Nathalie Cloutier; Isabelle Allaeys; Genevieve Marcoux; Kellie R Machlus; Benoit Mailhot; Anne Zufferey; Tania Levesque; Yann Becker; Nicolas Tessandier; Imene Melki; Huiying Zhi; Guy Poirier; Matthew T Rondina; Joseph E Italiano; Louis Flamand; Steven E McKenzie; Francine Cote; Bernhard Nieswandt; Waliul I Khan; Matthew J Flick; Peter J Newman; Steve Lacroix; Paul R Fortin; Eric Boilard
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-31       Impact factor: 11.205

3.  HO-1hi patrolling monocytes protect against vaso-occlusion in sickle cell disease.

Authors:  Yunfeng Liu; Fangmiao Jing; Woelsung Yi; Avital Mendelson; Patricia Shi; Ronald Walsh; David F Friedman; Caterina Minniti; Deepa Manwani; Stella T Chou; Karina Yazdanbakhsh
Journal:  Blood       Date:  2018-02-02       Impact factor: 22.113

4.  Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis.

Authors:  Jeeba Kuriakose; Vanessa Redecke; Cliff Guy; Jingran Zhou; Ruiqiong Wu; Sirish K Ippagunta; Heather Tillman; Patrick D Walker; Peter Vogel; Hans Häcker
Journal:  J Clin Invest       Date:  2019-04-29       Impact factor: 14.808

Review 5.  Effects of dyslipidaemia on monocyte production and function in cardiovascular disease.

Authors:  Mohammed Shamim Rahman; Andrew J Murphy; Kevin J Woollard
Journal:  Nat Rev Cardiol       Date:  2017-03-16       Impact factor: 32.419

6.  Intestinal IL-33 promotes platelet activity for neutrophil recruitment during acute inflammation.

Authors:  Zuojia Chen; Jialie Luo; Jian Li; Girak Kim; Andy Stewart; Yuefeng Huang; Chuan Wu
Journal:  Blood       Date:  2022-03-24       Impact factor: 22.113

Review 7.  Inflammatory Links Between Hypertriglyceridemia and Atherogenesis.

Authors:  Xueying Peng; Huaizhu Wu
Journal:  Curr Atheroscler Rep       Date:  2022-03-11       Impact factor: 5.967

Review 8.  Patrolling Mechanics of Non-Classical Monocytes in Vascular Inflammation.

Authors:  Konrad Buscher; Paola Marcovecchio; Catherine C Hedrick; Klaus Ley
Journal:  Front Cardiovasc Med       Date:  2017-12-19

9.  Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours.

Authors:  Adama Sidibe; Patricia Ropraz; Stéphane Jemelin; Yalin Emre; Marine Poittevin; Marc Pocard; Paul F Bradfield; Beat A Imhof
Journal:  Nat Commun       Date:  2018-01-24       Impact factor: 14.919

Review 10.  Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy.

Authors:  L M A Aparicio; I P Fernandez; J Cassinello
Journal:  Clin Transl Oncol       Date:  2017-04-13       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.